The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies

被引:3
作者
Grekhnev, Dmitriy A. [1 ]
Kruchinina, Anna A. [1 ]
Vigont, Vladimir A. [1 ]
Kaznacheyeva, Elena V. [1 ]
机构
[1] Russian Acad Sci, Inst Cytol, Dept Mol Physiol Cell, Lab Ion Channels Cell Membranes, 4 Tikhoretsky Ave, St Petersburg 194064, Russia
基金
俄罗斯科学基金会;
关键词
quinazoline derivatives; QNZ; EVP4593; calcium signaling; NF-kappa B signaling; store-operated calcium entry; Huntington's disease; huntingtin; neurodegeneration; oncology; NF-KAPPA-B; OPERATED CALCIUM-ENTRY; CA2+ ENTRY; THERAPEUTIC TARGET; POTENT INHIBITORS; STRUCTURAL CLASS; ACTIVATION; CELLS; COMPLEX; HOMEOSTASIS;
D O I
10.3390/ijms232415724
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quinazoline derivatives have various pharmacological activities and are widely used in clinical practice. Here, we reviewed the proposed mechanisms of the physiological activity of the quinazoline derivative EVP4593 and perspectives for its clinical implication. We summarized the accumulated data about EVP4593 and focused on its activities in different models of Huntington's disease (HD), including patient-specific iPSCs-based neurons. To make a deeper insight into its neuroprotective role in HD treatment, we discussed the ability of EVP4593 to modulate calcium signaling and reduce the level of the huntingtin protein. Moreover, we described possible protective effects of EVP4593 in other pathologies, such as oncology, cardiovascular diseases and parasite invasion. We hope that comprehensive analyses of the molecular mechanisms of EVP4593 activity will allow for the expansion of the scope of the EVP4593 application.
引用
收藏
页数:13
相关论文
共 70 条
[1]   The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway [J].
Aragao Macedo, Sharon Rose ;
de Figueiredo Nicolete, Larissa Deadame ;
Ferreira, Amalia dos Santos ;
de Barros, Neuza Biguinati ;
Nicolete, Roberto .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 28 (01) :554-559
[2]   Chemical Characteristics, Synthetic Methods, and Biological Potential of Quinazoline and Quinazolinone Derivatives [J].
Asif, Mohammad .
INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY, 2014, 2014
[3]   Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia [J].
Bassal, Mahmoud A. ;
Samaraweera, Saumya E. ;
Lim, Kelly ;
Bernard, Brooks A. ;
Bailey, Sheree ;
Kaur, Satinder ;
Leo, Paul ;
Toubia, John ;
Thompson-Peach, Chloe ;
Nguyen, Tran ;
Maung, Kyaw Ze Ya ;
Casolari, Debora A. ;
Iarossi, Diana G. ;
Pagani, Ilaria S. ;
Powell, Jason ;
Pitson, Stuart ;
Natera, Siria ;
Roessner, Ute ;
Lewis, Ian D. ;
Brown, Anna L. ;
Tenen, Daniel G. ;
Robinson, Nirmal ;
Ross, David M. ;
Majeti, Ravindra ;
Gonda, Thomas J. ;
Thomas, Daniel ;
D'Andrea, Richard J. .
NATURE COMMUNICATIONS, 2022, 13 (01)
[4]   A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease [J].
Becanovic, Kristina ;
Norremolle, Anne ;
Neal, Scott J. ;
Kay, Chris ;
Collins, Jennifer A. ;
Arenillas, David ;
Lilja, Tobias ;
Gaudenzi, Giulia ;
Manoharan, Shiana ;
Doty, Crystal N. ;
Beck, Jessalyn ;
Lahiri, Nayana ;
Portales-Casamar, Elodie ;
Warby, Simon C. ;
Connolly, Colum ;
DeSouza, Rebecca A. G. ;
Tabrizi, Sarah J. ;
Hermanson, Ola ;
Langbehn, Douglas R. ;
Hayden, Michael R. ;
Wasserman, Wyeth W. ;
Leavitt, Blair R. .
NATURE NEUROSCIENCE, 2015, 18 (06) :807-+
[5]   Calcium signaling and neurodegenerative diseases [J].
Bezprozvanny, Ilya .
TRENDS IN MOLECULAR MEDICINE, 2009, 15 (03) :89-100
[6]  
Bolteau R, 2022, EUR J MED CHEM, V241, DOI 10.1016/j.ejmech.2022.114620
[7]   Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine [J].
Bolteau, Raphael ;
Descamps, Florian ;
Ettaoussi, Mohamed ;
Caignard, Daniel H. ;
Delagrange, Philippe ;
Melnyk, Patricia ;
Yous, Said .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 189
[8]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[9]   The STIM1-Orai1 pathway of store-operated Ca2+ entry controls the checkpoint in cell cycle G1/S transition [J].
Chen, Yun-Wen ;
Chen, Yih-Fung ;
Chen, Ying-Ting ;
Chiu, Wen-Tai ;
Shen, Meng-Ru .
SCIENTIFIC REPORTS, 2016, 6
[10]   Antagonist of neuronal store-operated calcium entry exerts beneficial effects in neurons expressing PSEN1ΔE9 mutant linked to familial Alzheimer disease [J].
Chernyuk, Daria ;
Zernov, Nikita ;
Kabirova, Marina ;
Bezprozvanny, Ilya ;
Popugaeva, Elena .
NEUROSCIENCE, 2019, 410 :118-127